Benjamin Stone


Benjamin Stone is a Principal at Two River, and holds an interim senior leadership role at IconOVir Bio, Inc. Prior to Joining Two River, Mr. Stone led the Corporate Strategy function at Spark Therapeutics, Inc., playing an integral role in strategic planning, portfolio execution, and strategic transactions from 2016 until Spark’s acquisition by Roche. Prior to that, he held roles in Corporate and Business Development at Merrimack Pharmaceuticals, Inc., and in the Healthcare Investment Banking group at Credit Suisse. Benjamin received his B.S. in Economics from the Wharton School of the University of Pennsylvania, and his B.A. in International Studies from the University of Pennsylvania.